Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients

Natália B. do Amaral, Tamara Silva Rodrigues, Marcela C Giannini, Maria Isabel Fernandes Lopes, Letícia Pastorelli Bonjorno, Pamella Indira Menezes, SAULO MUSSE DIB, SAMARA LIBICH GUSMÃO GIGANTE, Maíra Nilson Benatti, Uebe C Rezek, Laerte L Emrich-Filho, Betania A A Sousa, Sergio C.L. de Almeida, Rodrigo Luppino Assad, Flávio P. Veras, Ayda Henriques Schneider, Luiz O S Leiria, Larissa D. Cunha, José C. Alves‐Filho, Thiago M. Cunha, Eurico Arruda, Carlos Henrique Miranda, Antônio Pazin‐Filho, Maria Auxiliadora‐Martins, Marcos de Carvalho Borges, Benedito A. Lopes da Fonseca, Valdes Roberto Bóllela, Cristina Marta Del‐Ben, Fernando Q. Cunha, Rodrigo de Carvalho Santana, Fernando Crivelenti Vilar, Dario S. Zamboni, P. Louzada-Junior, Renê Donizeti Ribeiro de Oliveira

2023Inflammation Research27 citationsDOI Open Access PDF

Topics & Concepts

ColchicineInflammasomePlaceboMedicineInternal medicineCytokine stormRegimenPharmacologyInterleukinGastroenterologyCoronavirus disease 2019 (COVID-19)CytokineReceptorPathologyDiseaseInfectious disease (medical specialty)Alternative medicineInflammasome and immune disordersCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19